Millennium Management
RNXT icon

Millennium Management’s RenovoRx RNXT Stock Holding History

Millennium Management’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76,814
Closed -$99.1K – 6322
2024
Q4 		$99.1K Sell
76,814
-5,539
-7% -$6.3K ﹤0.01% 5478
2024
Q3 		$87.3K Sell
82,353
-3,963
-5% -$4.44K ﹤0.01% 5607
2024
Q2 		$97.5K Buy
+86,316
New +$106K ﹤0.01% 5313

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Millennium Management's RNXT Position: Q1 2025 in Review

Millennium Management sold out of RenovoRx (RNXT) in Q1 2025, closing a stake of 76,814 shares — an estimated $99.1K sold.

Millennium Management first reported a position in RNXT in Q2 2024 and held it in 3 quarters. The position peaked at $99.1K in Q4 2024. 27 funds tracked by Wall St. Rank hold RNXT as of Q1 2025.

  • Millennium Management reported no remaining RenovoRx position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 76,814 RenovoRx shares in Q1 2025, an estimated $99.1K.
  • Millennium Management first reported a position in RenovoRx in Q2 2024 and held it in 3 quarters.
  • Millennium Management's RenovoRx position peaked at $99.1K in Q4 2024.
  • 27 funds tracked by Wall St. Rank held RenovoRx as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.